Prognostic Value of the Different Pre-Treatment Biomarkers for Patients with Neuroendocrine Tumors

#2266

Introduction: Several inflammatory response materials could be used for prediction of prognosis in cancer patients. The neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), thrombocytosis (the platelets number >400*103/mm3) have been introduced for prognostic scoring system in various cancers.

Aim(s): The objective of this study was to determine whether the NLR, the PLR or thrombocytosis could predict the clinical outcomes in G1-G2 neuroendocrine tumors.

Materials and methods: We performed a retrospective review of 31 patients with neuroendocrine tumors with ki 67 below 20% diagnosed in Fundeni Clinical Institute between 2011-2017. Data about site of the primary tumor, presence of metastasis, NLR, PLR, thrombocytosis (platelet count>400) and survival were collected and analysed.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: croitoru A

Authors: Grigorescu R, Croitoru A, Stanel I, Gheorghe C, Grama I,

Keywords: prognostic factors, survival,